CareDx (CDNA) | Stock Overview & Key Data
CareDx Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $99.83 on January 18, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CareDx
CDNA
|
1.09B Small-cap | 9.70% | 20.58% | 39.03% | 20.94% | 25.81% | 23.56% | 188.57% | -74.09% | 348.63% | 129.70% | 129.70% |
|
Thermo Fisher
TMO
|
174.55B Large-cap | 0.87% | 8.07% | 0.79% | -17.74% | -20.05% | 16.53% | -12.65% | -2.72% | 220.94% | 654.32% | 1,231.84% |
|
Danaher
DHR
|
126.39B Large-cap | -1.32% | 11.85% | -5.38% | -20.75% | -21.40% | -10.25% | -15.98% | -20.94% | 174.08% | 416.93% | 738.84% |
|
Genedx Holdings
WGS
|
1.94B Small-cap | 18.38% | 50.48% | -19.43% | -59.29% | -53.65% | -7.20% | 793.00% | 332.95% | 511.43% | 511.43% | 511.43% |
|
NeoGenomics
NEO
|
1.03B Small-cap | 1.28% | 34.59% | 34.59% | -6.96% | -5.70% | 57.71% | -33.31% | -74.14% | 39.90% | 751.15% | 1,822.41% |
|
Opko Health
OPK
|
936.60M Small-cap | -2.10% | 27.27% | 17.65% | 3.70% | 10.24% | 6.77% | -8.39% | -61.62% | -84.31% | -56.84% | 246.34% |
Ownership & Short Interest
Calculate Your CareDx Investment Returns
Long-Term Investment Performance Analysis
CareDx stock price in Jul 2016 was $4.72, A $1,000.00 lump sum investment in CareDx made 9 years ago would be worth approximately $5,101.69 today, representing a exceptional return of 410.17%. This translates to an annualized return (CAGR) of 17.88%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is CDNA's 52-week high and low?
- In the last 52 weeks, CareDx reached a high of $24.13 (on June 15, 2026) and a low of $10.96 (on July 17, 2025).
- What is the market cap and P/E ratio for CDNA?
- Curious about CareDx's size and valuation? Its market capitalization stands at 1.09B. When it comes to valuation, the P/E ratio (trailing twelve months) is 13.98, and the forward P/E (looking ahead) is 18.37.
- Does CDNA pay dividends? If so, what's the yield?
- As for dividends, CareDx isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are CareDx's main competitors or similar companies to consider before investing?
When looking at CareDx, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO174.55B Healthcare Diagnostics & Research 16.53% -12.65% Danaher
DHR126.39B Healthcare Diagnostics & Research -10.25% -15.98% Genedx Holdings
WGS1.94B Healthcare Diagnostics & Research -7.20% 793.00% NeoGenomics
NEO1.03B Healthcare Diagnostics & Research 57.71% -33.31% Opko Health
OPK936.60M Healthcare Diagnostics & Research 6.77% -8.39% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for CareDx Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of CareDx's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -6.27%, the Debt to Equity ratio from the most recent quarter is 8.64, and its Gross Profit Margin stands at 67.24%.
- What is the recent revenue and earnings growth for CDNA?
- Looking at CareDx's growth, its revenue over the trailing twelve months (TTM) was $380M. Compared to the same quarter last year (YoY), quarterly revenue grew by 25.20%, and quarterly earnings saw a YoY growth of 25.19%.
- How much of CDNA stock is held by insiders and institutions?
- Wondering who owns CareDx stock? Company insiders (like executives and directors) hold about 4.37% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 101.77%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.